Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Safety and Tolerance of Three Doses of G17DT in Patients With Metastatic Colorectal Cancer.

NCT02228785 is registered in ClinicalTrials.gov with Cancer Advances Inc. as lead sponsor.

NCT NCT02228785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02228785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Safety and Tolerance of Three Doses of G17DT in Patients With Metastatic Colorectal Cancer.
Lead sponsor
Cancer Advances Inc.
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 1994
Completion date
Not reported
Enrollment
5 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer